
Introduction
Expert Post-Market Surveillance (PMS) for Medical Devices
At QAEC Limited, we help medical-device manufacturers and life-science organisations design, implement, and maintain compliant Post-Market Surveillance (PMS) systems.
Our consultancy ensures your PMS processes meet the requirements of EU MDR 2017/745, EU IVDR 2017/746, and UK MDR 2002 PMS Statutory Instrument (SI 2024), in force from 16 June 2025.
We translate complex regulatory requirements into clear, practical systems that protect patient safety, maintain product performance, and keep your organisation audit-ready.
Why Post-Market Surveillance Matters
Effective PMS is no longer just a regulatory obligation, it’s a cornerstone of product lifecycle management and ongoing market access.
- Demonstrates continuous product safety and performance under MDR Annex III & Article 83.
- Enables early detection of trends and supports vigilance reporting through the MHRA MORE portal.
- Integrates PMS outputs into risk management (ISO 14971) and clinical evaluation updates.
- Provides evidence required by the new EU Product Liability Directive, ensuring manufacturers can ensure product safety.
Whatever stage you are at, QAEC Limited provides clear, practical, and cost-effective support for your post-market surveillance requirements.
How Can We Help?
PMS Consultancy Services
QAEC Limited delivers end-to-end PMS support tailored to your device type, regulatory framework, and quality management system (QMS), ensuring alignment with current MDR, IVDR, and UK PMS requirements.
PMS Plans & Reports – Develop and maintain PMS Plans, PSURs, and SSCPs. Integrate findings into technical files to maintain certification and audit readiness.
Regulatory Compliance – Ensure alignment with EU MDR, IVDR, UK MDR, the UK PMS Statutory Instrument (SI 2024). Support with MHRA, UKCA, and SOTA requirements in PMS and clinical evaluations.
Vigilance & Incident Reporting – Implement systems for adverse event reporting and FSCAs, with expert guidance on MHRA MORE Portal submissions and global vigilance processes.
Supply Chain & 3PL – Embed PMS and vigilance obligations into supplier, importer, distributor, and 3PL (Third-Party Logistics) contracts, and ensure partners maintain traceability and support complaints, recalls, and reporting under MDR and UK MDR.
Risk Management – Analyse complaint, PMCF, and field data to identify risks and feed PMS outputs into CAPA and risk-management systems to drive continuous improvement, aligned with ISO 14971.
Audit & Inspection Readiness – PMS-specific gap analyses, documentation reviews and preparation for MHRA and Notified Body audits. Closure of CAPA actions to resolve findings, maintain compliance and prevent recurrence. Ensure PMS records, technical files, and CAPA evidence are complete and inspection-ready.

Company Insights
What Our Clients Say
Charles was extremely accommodating, in that he was able to step into a Quality Manager position temporarily. He quickly established a good working relationship with the team and provided the necessary support across both QC and QA functions.
His knowledge of our industry and, therefore, our Regulatory requirements was excellent, and his input for potential future improvements provided a valued insight. The team were grateful for his support and took on board his forward-thinking approach.
Ed provided expert guidance and support for a number of quality, regulatory and design/development process improvements. Ed also provided hands-on input to process and document creation and review activities.
Ed clearly has extensive and relevant experience and is a subject matter expert on quality and regulatory matters relating to the development and market approval of medical devices.
QAEC Limited provided Quality Assurance and Regulatory Affairs support services in relation to Internal Audits, MDR 2017/745 related activities and other QARA support functions as necessary, working closely with my team within Quality and Regulatory successfully addressing and meeting our set objectives.
I would highly recommend Charles (Ed) Spearpoint, QARA Consultant at QAEC Limited, for his expertise and flexible and helpful approach, as he was a pleasure to work with. QAEC Limited are a great company, very efficient and professional.
As Lead MDR Consultant, Ed worked closely alongside myself and my team within QA, to initially conduct a gap analysis approach against the requirements of MDR 2017/745 and then to lead and support remediation of corresponding procedures and processes in collaboration with departments and SMEs within our organisation.
During his time on site, Ed demonstrated a thorough understanding and working knowledge of the MDR 2017/745 regulation, its interaction with our ISO13485: 2016 Quality Management System, and all associated elements.
Charles (Ed) Spearpoint assisted with the daily handling of our QA Departments and assisted in supporting our FDA remediation. Ed has shown a very high level of quality in his work and his approach. He has given the organisation a fresh breath, and he contributed with professional participation, being a part of both my Worldwide QA team and the local management team.
Ed has shown strong leadership and you can clearly feel he is very experienced in this area. I only have positive feedback to give around Ed and will recommend him anytime.
Charles (Ed) Spearpoint was utilised in a support capacity in our transition project from MDD to EU MDR 2017/745 for Medical Devices. Ed provided technical guidance, support and direction coupled with key tasks involved in the compilation of the identified technical files.
He has been proactive and has worked collaboratively within the business to bring about the deliverables in meeting the regulations, bringing challenge to what is actually required against the new regulations and how this is embedded within the standard ways of working within our business, successfully navigating areas of complexity and ambiguity. As part of his role, Ed has also rolled out awareness training aligned to MDR 2017/745.
Charles Spearpoint's consulting services were used by us to assist in the implementation of the MDSAP standard.
With Charles’s guidance, we successfully went through the first stage audits for MDSAP and successfully went through certificate renewal for ISO 13485: 2016, ISO 9001: 2015 and the Medical Device Directive.
With Charles’s assistance we are in a far more stronger position for compliance and regulatory activities. We will use QAEC Limited consulting services again when required and would recommend their services to other companies.
Charles was extremely accommodating, in that he was able to step into a Quality Manager position temporarily. He quickly established a good working relationship with the team and provided the necessary support across both QC and QA functions.
His knowledge of our industry and, therefore, our Regulatory requirements was excellent, and his input for potential future improvements provided a valued insight. The team were grateful for his support and took on board his forward-thinking approach.
Ed provided expert guidance and support for a number of quality, regulatory and design/development process improvements. Ed also provided hands-on input to process and document creation and review activities.
Ed clearly has extensive and relevant experience and is a subject matter expert on quality and regulatory matters relating to the development and market approval of medical devices.
QAEC Limited provided Quality Assurance and Regulatory Affairs support services in relation to Internal Audits, MDR 2017/745 related activities and other QARA support functions as necessary, working closely with my team within Quality and Regulatory successfully addressing and meeting our set objectives.
I would highly recommend Charles (Ed) Spearpoint, QARA Consultant at QAEC Limited, for his expertise and flexible and helpful approach, as he was a pleasure to work with. QAEC Limited are a great company, very efficient and professional.
As Lead MDR Consultant, Ed worked closely alongside myself and my team within QA, to initially conduct a gap analysis approach against the requirements of MDR 2017/745 and then to lead and support remediation of corresponding procedures and processes in collaboration with departments and SMEs within our organisation.
During his time on site, Ed demonstrated a thorough understanding and working knowledge of the MDR 2017/745 regulation, its interaction with our ISO13485: 2016 Quality Management System, and all associated elements.
Charles (Ed) Spearpoint assisted with the daily handling of our QA Departments and assisted in supporting our FDA remediation. Ed has shown a very high level of quality in his work and his approach. He has given the organisation a fresh breath, and he contributed with professional participation, being a part of both my Worldwide QA team and the local management team.
Ed has shown strong leadership and you can clearly feel he is very experienced in this area. I only have positive feedback to give around Ed and will recommend him anytime.
Charles (Ed) Spearpoint was utilised in a support capacity in our transition project from MDD to EU MDR 2017/745 for Medical Devices. Ed provided technical guidance, support and direction coupled with key tasks involved in the compilation of the identified technical files.
He has been proactive and has worked collaboratively within the business to bring about the deliverables in meeting the regulations, bringing challenge to what is actually required against the new regulations and how this is embedded within the standard ways of working within our business, successfully navigating areas of complexity and ambiguity. As part of his role, Ed has also rolled out awareness training aligned to MDR 2017/745.
Charles Spearpoint's consulting services were used by us to assist in the implementation of the MDSAP standard.
With Charles’s guidance, we successfully went through the first stage audits for MDSAP and successfully went through certificate renewal for ISO 13485: 2016, ISO 9001: 2015 and the Medical Device Directive.
With Charles’s assistance we are in a far more stronger position for compliance and regulatory activities. We will use QAEC Limited consulting services again when required and would recommend their services to other companies.
Get Compliance Clarity
Why Choose Us
-
Proven Track Record
Global expertise in quality assurance and regulatory affairs for a variety of industries, ensuring global regulatory standards are met.
-
Customised Solutions
Tailored consultancy to meet your specific business needs.
-
MDR and IVDR Experts
Successful transition to MDR 2017/745 and IVDR 2017/746.
-
End-to-End Support
From setup and validation to ongoing audit support, we ensure continuous compliance and quality.
-
Our Flexible Resource
Monthly retainer, short-term, interim, or long-term quality or regulatory support, we can help you meet your goals cost-effectively.